PDS Biotechnology Corp — Director's Dealing 2020

Dec 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2020-12-08

Reporting Person: King Michael N. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-08	Stock Option (Right to Buy)	$2.43	A	50000	Acquired	2030-12-08	Common Stock (50000)	Direct

Footnotes

F1: The option is fully vested and immediately exercisable as of the date of grant.